AMSTERDAM, NETHERLANDS – September 22, 2020 – Synaffix B.V., a biotechnology companyenabling antibody-drug conjugates (ADCs) with best-in-class therapeutic index, announces thatit has won the “Best ADC Platform Technology” category at the 2020 World ADC...
● Multi-year strategic collaboration in target discovery and therapeutic developmentbased on Scenic Biotech’s disease modifying approach● Utilises Scenic’s unique Cell-Seq platform and its proprietary data warehouse ofgenetic modifiers● Scenic Biotech will receive an...
Download pdf AMSTERDAM, NETHERLANDS – July 23, 2020 – Synaffix B.V., a biotechnology company focused on enabling antibody-drug conjugates (ADCs) with superior therapeutic index based on its proprietary ADC technology platform, announces that ADC Therapeutics SA has...
Download pdf Oss, The Netherlands, July 21, 2020 —Citryll announced its Board has been strengthened with twoindustry veterans with impressive track-records, Businesswire Citryll. Paul Peter Tak, MD, PhD served as Professor of Medicine and Chair of the Department of...
Download pdf Clinical trajectory initiated towards development of novel treatment for dyslipidaemia Nijmegen, The Netherlands, 21 July 2020 – Staten Biotechnology B.V. announced today the initiation of dosing of the Company’s lead asset, STT-5058, in a First-in-Human...
